1.Message from the Editor-in-Chief: Theranostic Imaging in 2018
Nuclear Medicine and Molecular Imaging 2018;52(2):87-88
No abstract available.
Theranostic Nanomedicine
2.Contribution of Radionuclide Theranostics for Managing Intractable Malignancies
Nuclear Medicine and Molecular Imaging 2018;52(3):168-169
No abstract available.
Theranostic Nanomedicine
3.Nanomedicine Approaches for Treatment of Menopausal Symptoms.
Fatemeh ABDI ; Fahimeh RAMEZANI TEHRANI ; Hamid MOBEDI ; Mahrokh DOLATIAN ; Nariman MOSAFFA
Journal of Menopausal Medicine 2016;22(3):127-128
No abstract available.
Nanomedicine*
4.Nuclear Theranostics in Asia: In vivo Companion Diagnostics
Nuclear Medicine and Molecular Imaging 2019;53(1):1-6
No abstract available.
Asia
;
Friends
;
Humans
;
Theranostic Nanomedicine
5.Nuclear Theranostics in Indonesia: Past, Present, and Future
Nuclear Medicine and Molecular Imaging 2019;53(1):33-34
Nuclear medicine in Indonesia has a quite long history since the late 1960s. There are some problems and obstacles that have to be solved and overcome in order to develop nuclear medicine services, spread the services to reach every target area, and implement new novel therapeutic nuclear medicine as well. The right strategy and strong effort should be performed for a successful result. Theranostics nuclear medicine will play a more prominent role in the management of cancer patients.
Humans
;
Indonesia
;
Nuclear Medicine
;
Theranostic Nanomedicine
6.Review: optically-triggered phase-transition droplets for photoacoustic imaging.
Qiyang CHEN ; Jaesok YU ; Kang KIM
Biomedical Engineering Letters 2018;8(2):223-229
Optically-triggered phase-transition droplets have been introduced as a promising contrast agent for photoacoustic and ultrasound imaging that not only provide significantly enhanced contrast but also have potential as photoacoustic theranostic molecular probes incorporated with targeting molecules and therapeutics. For further understanding the dynamics of optical droplet vaporization process, an innovative, methodical analysis by concurrent acoustical and ultrafast optical recordings, comparing with a theoretical model has been employed. In addition, the repeatability of the droplet vaporization-recondensation process, which enables continuous photoacoustic imaging has been studied through the same approach. Further understanding the underlying physics of the optical droplet vaporization and associated dynamics may guide the optimal design of the droplets. Some innovative approaches in preclinical studies have been recently demonstrated, including sono-photoacoustic imaging, dual-modality of photoacoustic and ultrasound imaging, and super-resolution photoacoustic imaging. In this review, current development of optically triggered phase-transition droplets and understanding on the vaporization dynamics, their applications are introduced and future directions are discussed.
Methods
;
Models, Theoretical
;
Molecular Probes
;
Theranostic Nanomedicine
;
Ultrasonography
;
Volatilization
7.Nuclear Medicine Theranostics: Perspective from Pakistan
Humayun BASHIR ; M Numair YOUNIS ; M Rehan GUL
Nuclear Medicine and Molecular Imaging 2019;53(1):38-41
Nuclear medicine has been offering diagnostic and therapeutic solution since the introduction of radioactive iodine for thyroid diseases since decades. However, the concept of theranostics has given a new found impetus to the use of pairs of radiopharmaceuticals for diagnosis and treatment. Presented here is a perspective on theranostics from Pakistan.
Diagnosis
;
Iodine
;
Nuclear Medicine
;
Pakistan
;
Radiopharmaceuticals
;
Theranostic Nanomedicine
;
Thyroid Diseases
8.Perspectives for Concepts of Individualized Radionuclide Therapy, Molecular Radiotherapy, and Theranostic Approaches
Nuclear Medicine and Molecular Imaging 2019;53(3):167-171
Radionuclide therapy (RNT) stands on the delivery of radiation to tumors or non-tumor target organs using radiopharmaceuticals that are designed to have specific affinity to targets. RNT is recently called molecular radiotherapy (MRT) by some advocators in order to emphasize its characteristics as radiotherapy and the relevance of dosimetry-guided optimization of treatment. Moreover, RNT requires relevant radiation protection standards because it employs unsealed radionuclides and gives therapeutic radiation doses in humans. On the basis of these radiation protection standards, the development and use of radiopharmaceuticals for combined application through diagnostics and therapeutics lead to theranostic approaches that will enhance the efficacy and safety of treatment by implementing dosimetry-based individualization.
Humans
;
Radiation Protection
;
Radioisotopes
;
Radiopharmaceuticals
;
Radiotherapy
;
Theranostic Nanomedicine
9.Radio-graphene in Theranostic Perspectives
Nuclear Medicine and Molecular Imaging 2017;51(1):17-21
Owing to its unique physicochemical properties such as high surface area, notable biocompatibility, robust mechanical strength, high thermal conductivity, and ease of functionalization, 2D-layered graphene has received tremendous attention as a futuristic nanomaterial and its-associated research has been rapidly evolving in a variety of fields.With the remarkable advances of graphene especially in the biomedical realm, in vivo evaluation techniques to examine in vivo behavior of graphene are largely demanded under the hope of clinical translation. Many different types of drugs such as the antisense oligomer and chemotherapeutics require optimal delivery conveyor and graphene is now recognized as a suitable candidate due to its simple and high drug loading property. Termed as ‘ radio-graphene’, radioisotope-labeled graphene approach was recently harnessed in the realm of biomedicine including cancer diagnosis and therapy, contributing to the acquisition of in vivo information for targeted drug delivery. In this review, we highlight current examples for bioapplication of radiolabeled graphene with brief perspectives on future strategies in its extensive bio- or clinical applications.
Diagnosis
;
Graphite
;
Hope
;
Nanostructures
;
Theranostic Nanomedicine
;
Thermal Conductivity
10.Theranostics Based on Liposome: Looking Back and Forward
Nuclear Medicine and Molecular Imaging 2019;53(4):242-246
Liposome is one of the oldest yet most successful nanomedicine platforms. Doxil®, PEGylated liposome loaded with doxorubicin (DOX), was approved by the FDA in 1995 for the treatment of AIDS-related Kaposi's sarcoma, and it was the first approval for nanomedicine. Since then, liposome-based therapeutics were approved for the treatment of various diseases and many clinical trials are underway. The success of the liposome-based therapeutics was due to following factors: (1) ease of synthesis, (2) biocompatibility, (3) the ability to load both hydrophilic and hydrophobic agents, and (4) long circulation property after application of polyethylene glycol (PEG). Recently, more functionalities are introduced to liposome platform, which are (1) in vivo imaging probes for optical, magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission computed tomography (SPECT), (2) pH and temperature-sensitive lipid moiety, and (3) novel agents for photodynamic and photothermal therapies (PDT, PTT). These conventional and newly tested advantages make the liposome to be one of the most promising nanoplatforms for theranostics.
Doxorubicin
;
Hydrogen-Ion Concentration
;
Liposomes
;
Magnetic Resonance Imaging
;
Nanomedicine
;
Polyethylene Glycols
;
Positron-Emission Tomography
;
Sarcoma, Kaposi
;
Theranostic Nanomedicine
;
Tomography, Emission-Computed